Your browser doesn't support javascript.
loading
Optimal dosing of high-dose melphalan prior to autologous hematopoietic stem cell transplantation in a patient with AL amyloidosis and a solitary kidney.
Lee, Shin Yin; Brauneis, Dina; Stern, Lauren; Sanchorawala, Vaishali.
Afiliación
  • Lee SY; Amyloidosis Center, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA; Section of Hematology/Oncology, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA.
  • Brauneis D; Amyloidosis Center, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA; Section of Hematology/Oncology, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA.
  • Stern L; Amyloidosis Center, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA; Section of Nephrology, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA.
  • Sanchorawala V; Amyloidosis Center, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA; Section of Hematology/Oncology, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA. Electronic address: vaishali.sanchorawala@bm
Hematol Oncol Stem Cell Ther ; 9(2): 86-8, 2016 Jun.
Article en En | MEDLINE | ID: mdl-26303745

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Amiloidosis / Riñón / Melfalán Límite: Humans Idioma: En Revista: Hematol Oncol Stem Cell Ther Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Amiloidosis / Riñón / Melfalán Límite: Humans Idioma: En Revista: Hematol Oncol Stem Cell Ther Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos